These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29540187)

  • 1. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.
    Ma QL; Wang JH; Yang M; Wang HP; Jin J
    J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
    Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
    EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.
    Lin X; Ling Q; Lv Y; Ye W; Huang J; Li X; Guo Q; Wang J; Li Z; Jin J
    Cancer Biomark; 2020; 28(2):151-158. PubMed ID: 32176633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
    Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
    Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
    J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
    Eisfeld AK; Marcucci G; Maharry K; Schwind S; Radmacher MD; Nicolet D; Becker H; Mrózek K; Whitman SP; Metzeler KH; Mendler JH; Wu YZ; Liyanarachchi S; Patel R; Baer MR; Powell BL; Carter TH; Moore JO; Kolitz JE; Wetzler M; Caligiuri MA; Larson RA; Tanner SM; de la Chapelle A; Bloomfield CD
    Blood; 2012 Jul; 120(2):249-58. PubMed ID: 22529287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
    Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
    Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
    Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
    Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
    Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
    Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
    Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
    J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
    Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
    Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of miR-196a/b expression in adult acute myeloid leukaemia: a single-centre, retrospective cohort study.
    Zhang J; Liu W; Du J; Jin Y; Zhao M; Li L; Wang Y
    J Int Med Res; 2018 Sep; 46(9):3675-3683. PubMed ID: 29865918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.